{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"973c8bf31a78a6f9c8d9836e1e14d178001b74621a4a6bd4316564180e1f1bf2","attributes":{"feedName":"fda","feedSource":"fda","title":"SCA Pharmaceuticals LLC. Issues Voluntary Nationwide Recall of Furosemide 100 mg in 0.9% Sodium Chloride due to Presence of Precipitate","description":", SCA Pharmaceuticals LLC (“SCA Pharma”) is voluntarily recalling 7 lots of the injectable product Furosemide 100 mg in 0.9% Sodium Chloride 100 mg bag to the consumer level. This product is being recalled for visible particulate matter believed to be furosemide precipitate.","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sca-pharmaceuticals-llc-issues-voluntary-nationwide-recall-furosemide-100-mg-09-sodium-chloride-due","publicationDate":"2018-09-07T13:40:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["drugs"],"contaminants":[],"distribution":["CT","DC","VA"],"risk":"possible","token":"5d9e68878b079e002a250a66"}}}